European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Community Register of medicinal products
Community list of not active medicinal products for human use |
WITHDRAWN |
Product information |
| Invented name: | ACOMPLIA |
| Auth. number : | EU/1/06/344 |
| INN : | Rimonabant |
| ATC: | A - Alimentary tract and metabolism A08 - Antiobesity preparations, excluding diet products A08A - Antiobesity preparations, excluding diet products A08AX - Other antiobesity drugs A08AX01 - Rimonabant (See WHO ATC Index) |
| Indication: | As an adjunct to diet and exercise for the treatment of obese patients |
| Marketing Authorisation Holder: | Sanofi-Aventis
174 avenue de France, F-75013 Paris, France |
EPAR and active package presentations
Package presentations
|
The section of the Community Register "Package presentations" will no longer be updated as from 2 November 2012.
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information". Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register. |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 21/06/2006 | Centralised - Authorisation | EMEA/H/C/666 | (2006)2888 of 19/06/2006 | |||
| 03/08/2006 | Centralised - Variation | EMEA/H/C/666/IA/1 | ||||
| 16/08/2006 | Centralised - Variation | EMEA/H/C/666/IB/2 | ||||
| Updated with Decision(2007)1488 of 27/03/2007 | ||||||
| 14/09/2006 | Centralised - Variation | EMEA/H/C/666/IA/3 | ||||
| 23/03/2007 | Centralised - Variation | EMEA/H/C/666/IA/6 | ||||
| Updated with Decision(2007)4196 of 31/08/2007 | ||||||
| 23/03/2007 | Centralised - Variation | EMEA/H/C/666/IA/5 | ||||
| Updated with Decision(2007)4196 of 31/08/2007 | ||||||
| 29/03/2007 | Centralised - Variation | - | (2007)1488 of 27/03/2007 | |||
| 04/07/2007 | Centralised - Variation | EMEA/H/C/666/IB/7 | ||||
| Updated with Decision(2007)4196 of 31/08/2007 | ||||||
| 08/08/2007 | Centralised - Variation | EMEA/H/C/666/IB/9 | ||||
| 06/09/2007 | Centralised - Variation | EMEA/H/C/666/II/8 | (2007)4196 of 31/08/2007 | |||
| 25/10/2007 | Centralised - Variation | EMEA/H/C/666/II/4 | (2007)5272 of 23/10/2007 | |||
| 29/01/2008 | Centralised - Variation | EMEA/H/C/666/II/10 | ||||
| 23/07/2008 | Centralised - Variation | EMEA/H/C/666/II/1 | (2008)3917 of 17/07/2008 | |||
| 17/11/2008 | Referral | EMEA/H/C/666/A-20/12 | (2008)6991 of 13/11/2008 | |||
| 20/01/2009 | Centralised - Withdrawal | - | (2009)240 of 16/01/2009 |